Phase II Maraviroc for GVHD Prevention
Clinical trial NCT01785810 · COMPLETED
Trial details
- NCT number
- NCT01785810
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2016-11-11
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.